Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs)

BACKGROUND: The development of new therapies for orphan genetic diseases represents an extremely important medical and social challenge. Drug repositioning, i.e. finding new indications for approved drugs, could be one of the most cost- and time-effective strategies to cope with this problem, at lea...

Descripción completa

Detalles Bibliográficos
Autores principales: Molineris, Ivan, Ala, Ugo, Provero, Paolo, Di Cunto, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851137/
https://www.ncbi.nlm.nih.gov/pubmed/24088245
http://dx.doi.org/10.1186/1471-2105-14-288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851137/
https://www.ncbi.nlm.nih.gov/pubmed/24088245
http://dx.doi.org/10.1186/1471-2105-14-288

Ejemplares similares